Issue 9, 2016

Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening

Abstract

Rho-associated protein kinase (ROCK) mediated the reorganization of the actin cytoskeleton and has been implicated in the spread and metastatic process of cancer. In this study, structure-based high-throughput virtual screening was used to identify candidate compounds targeting ROCK2 from a chemical library. Moreover, high-content screening based on neurite outgrowth of SH-SY5Y cells (a human neuroblastoma cell line) was used for accelerating the identification of compounds with characteristics of ROCK2 inhibitors. The effects of bioactive ROCK2 inhibitor candidates were further validated using other bioassays including cell migration and wound healing in SH-SY5Y cells. Through the combined virtual and high-content drug screening, the compound 1,3-benzodioxol-5-yl[1-(5-isoquinolinylmethyl)-3-piperidinyl]-methanone (BIPM) was identified as a novel and potent ROCK2 inhibitor. Exposure of SH-SY5Y cells to BIPM led to significant changes in neurite length, cell migration and actin stress fibers. Further experiments demonstrated that BIPM was able to significantly inhibit phosphorylation of cofilin, a regulatory protein of actin cytoskeleton. These results suggest that BIPM could be considered as a promising scaffold for the further development of ROCK2 inhibitors for anti-cancer metastasis.

Graphical abstract: Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening

Supplementary files

Article information

Article type
Paper
Submitted
29 apr. 2016
Accepted
31 maí 2016
First published
31 maí 2016

Mol. BioSyst., 2016,12, 2713-2721

Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening

C. Chong, M. Kou, P. Pan, H. Zhou, N. Ai, C. Li, H. Zhong, C. Leung, T. Hou and S. M. Lee, Mol. BioSyst., 2016, 12, 2713 DOI: 10.1039/C6MB00343E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements